Abstract:Infections caused by multidrug-resistant (MDR) bacteria are becoming a serious threat to public health worldwide. With an ever-reducing pipeline of last-resort drugs further complicating the current dire situation arising due to antibiotic resistance, there has never been a greater urgency to attempt to discover potential new antibiotics. The use of nanotechnology, encompassing a broad range of organic and inorganic nanomaterials, offers promising solutions. Organic nanomaterials, including lipid-, polymer-, and carbon-based nanomaterials, have inherent antibacterial activity or can act as nanocarriers in delivering antibacterial agents. Nanocarriers, owing to the protection and enhanced bioavailability of the encapsulated drugs, have the ability to enable an increased concentration of a drug to be delivered to an infected site and reduce the associated toxicity elsewhere. On the other hand, inorganic metal-based nanomaterials exhibit multivalent antibacterial mechanisms that combat MDR bacteria effectively and reduce the occurrence of bacterial resistance. These nanomaterials have great potential for the prevention and treatment of MDR bacterial infection. Recent advances in the field of nanotechnology are enabling researchers to utilize nanomaterial building blocks in intriguing ways to create multi-functional nanocomposite materials. These nanocomposite materials, formed by lipid-, polymer-, carbon-, and metal-based nanomaterial building blocks, have opened a new avenue for researchers due to the unprecedented physiochemical properties and enhanced antibacterial activities being observed when compared to their mono-constituent parts. This review covers the latest advances of nanotechnologies used in the design and development of nano- and nanocomposite materials to fight MDR bacteria with different purposes. Our aim is to discuss and summarize these recently established nanomaterials and the respective nanocomposites, their current application, and challenges for use in applications treating MDR bacteria. In addition, we discuss the prospects for antimicrobial nanomaterials and look forward to further develop these materials, emphasizing their potential for clinical translation.

Interaction of MscL with antibiotics and its potential use

Metallo-ß-lactamases: a review

Biological characteristics of mechanosensitive channels MscS and MscL in Actinobacillus pleuropneumoniae

Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment

Antimicrobial Peptides: From Design to Clinical Application

Unveiling Synergistic Potency: Exploring Butyrolactone I to Enhance Gentamicin Efficacy against Methicillin-Resistant Staphylococcus aureus (MRSA) Strain USA300

Macrolide antibiotic interaction and resistance on the bacterial ribosome

A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens

Regulatory mechanisms of sub-inhibitory levels antibiotics agent in bacterial virulence

Metallophthalocyanine as ideal antibiotics without light: Mechanisms and applications

Structure and mechanism of potent bifunctional β-lactam- and homoserine lactone-degrading enzymes from marine microorganisms

Probing the interaction between the metallo‐β‐lactamase SMB‐1 and ampicillin by multispectral approaches combined with molecular dynamics

Targeting Bacterial Phospholipids and Their Synthesis Pathways for Antibiotic Discovery

Current Development of Thiazole-Containing Compounds as Potential Antibacterials against Methicillin-Resistant Staphylococcus aureus

Recent Advances in the Development of Lipid-, Metal-, Carbon-, and Polymer-Based Nanomaterials for Antibacterial Applications

Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors

Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii

Intragenic Suppression of Gain‐of‐function Mutations in the Escherichia Coli Mechanosensitive Channel, MscL

Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery

The role of Mfd in Mycobacterium tuberculosis physiology and underlying regulatory network

A new therapeutic strategy for infectious diseases against intracellular multidrug-resistant bacteria